These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23859553)

  • 1. In vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approaches.
    Balducci C; Forloni G
    Curr Pharm Des; 2014; 20(15):2491-505. PubMed ID: 23859553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
    Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
    Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
    Sharma S; Verma S; Kapoor M; Saini A; Nehru B
    Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein.
    Balducci C; Beeg M; Stravalaci M; Bastone A; Sclip A; Biasini E; Tapella L; Colombo L; Manzoni C; Borsello T; Chiesa R; Gobbi M; Salmona M; Forloni G
    Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2295-300. PubMed ID: 20133875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases.
    Brkic M; Balusu S; Van Wonterghem E; Gorlé N; Benilova I; Kremer A; Van Hove I; Moons L; De Strooper B; Kanazir S; Libert C; Vandenbroucke RE
    J Neurosci; 2015 Sep; 35(37):12766-78. PubMed ID: 26377465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease-like pathology induced by amyloid-β oligomers in nonhuman primates.
    Forny-Germano L; Lyra e Silva NM; Batista AF; Brito-Moreira J; Gralle M; Boehnke SE; Coe BC; Lablans A; Marques SA; Martinez AM; Klein WL; Houzel JC; Ferreira ST; Munoz DP; De Felice FG
    J Neurosci; 2014 Oct; 34(41):13629-43. PubMed ID: 25297091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Alzheimer's disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid β oligomers.
    Ochiishi T; Kaku M; Kiyosue K; Doi M; Urabe T; Hattori N; Shimura H; Ebihara T
    Sci Rep; 2019 Nov; 9(1):17368. PubMed ID: 31757975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies for Improving a Rat Model of Alzheimer's Disease: Icv Administration of Well-Characterized β-Amyloid 1-42 Oligomers Induce Dysfunction in Spatial Memory.
    Kasza Á; Penke B; Frank Z; Bozsó Z; Szegedi V; Hunya Á; Németh K; Kozma G; Fülöp L
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29156571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Down-Expression of ACE and IDE Exacerbates Exogenous Amyloid-β Neurotoxicity in CB2R-/- Mice.
    Wang L; Shi FX; Xu WQ; Cao Y; Li N; Li M; Wang Q; Wang JZ; Tian Q; Yu LK; Zhou XW
    J Alzheimers Dis; 2018; 64(3):957-971. PubMed ID: 29991137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin.
    Wang T; Xie XX; Ji M; Wang SW; Zha J; Zhou WW; Yu XL; Wei C; Ma S; Xi ZY; Pang GL; Liu RT
    Neuropharmacology; 2016 Jun; 105():561-576. PubMed ID: 26907803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer's disease.
    Balducci C; Frasca A; Zotti M; La Vitola P; Mhillaj E; Grigoli E; Iacobellis M; Grandi F; Messa M; Colombo L; Molteni M; Trabace L; Rossetti C; Salmona M; Forloni G
    Brain Behav Immun; 2017 Feb; 60():188-197. PubMed ID: 27751869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.
    Nimmrich V; Ebert U
    Rev Neurosci; 2009; 20(1):1-12. PubMed ID: 19526730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bis(propyl)-cognitin Prevents β-amyloid-induced Memory Deficits as Well as Synaptic Formation and Plasticity Impairments via the Activation of PI3-K Pathway.
    Jiang L; Huang M; Xu S; Wang Y; An P; Feng C; Chen X; Wei X; Han Y; Wang Q
    Mol Neurobiol; 2016 Aug; 53(6):3832-3841. PubMed ID: 26160762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel antibody targeting sequence 31-35 in amyloid β protein attenuates Alzheimer's disease-related neuronal damage.
    Cheng L; Zhang J; Li XY; Yuan L; Pan YF; Chen XR; Gao TM; Qiao JT; Qi JS
    Hippocampus; 2017 Feb; 27(2):122-133. PubMed ID: 27784133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent.
    Puzzo D; Piacentini R; Fá M; Gulisano W; Li Puma DD; Staniszewski A; Zhang H; Tropea MR; Cocco S; Palmeri A; Fraser P; D'Adamio L; Grassi C; Arancio O
    Elife; 2017 Jul; 6():. PubMed ID: 28696204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cell-permeable Aβ1-6A2VTAT(D) peptide reverts synaptopathy induced by Aβ1-42wt.
    Cimini S; Sclip A; Mancini S; Colombo L; Messa M; Cagnotto A; Di Fede G; Tagliavini F; Salmona M; Borsello T
    Neurobiol Dis; 2016 May; 89():101-11. PubMed ID: 26721320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.